share_log

Bruush Oral Care | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Bruush Oral Care | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Bruush Oral Care | 6-K：外國發行人報告
SEC announcement ·  03/23 05:18
牛牛AI助理已提取核心訊息
Bruush Oral Care Inc. has been notified by the Nasdaq Stock Market of non-compliance with the minimum bid price and low priced stocks rules, which are prerequisites for continued listing on the Nasdaq Capital Market. The company's securities are at risk of being delisted due to the bid price falling below $1.00 for 30 consecutive trading days and reaching $0.10 or less for ten consecutive trading days. Bruush Oral Care has requested a hearing with the Nasdaq Hearings Panel, scheduled for April 25, 2024, to appeal the delisting determination. The hearing's outcome is uncertain. Additionally, the company has received a notice regarding the delinquency in filing its annual report on Form 20-F for the fiscal year ended October 31, 2023. This filing delay serves as another basis for potential delisting. Bruush Oral Care must present a compliance plan to address the filing requirement by April 5, 2024, which will also be reviewed during the April hearing.
Bruush Oral Care Inc. has been notified by the Nasdaq Stock Market of non-compliance with the minimum bid price and low priced stocks rules, which are prerequisites for continued listing on the Nasdaq Capital Market. The company's securities are at risk of being delisted due to the bid price falling below $1.00 for 30 consecutive trading days and reaching $0.10 or less for ten consecutive trading days. Bruush Oral Care has requested a hearing with the Nasdaq Hearings Panel, scheduled for April 25, 2024, to appeal the delisting determination. The hearing's outcome is uncertain. Additionally, the company has received a notice regarding the delinquency in filing its annual report on Form 20-F for the fiscal year ended October 31, 2023. This filing delay serves as another basis for potential delisting. Bruush Oral Care must present a compliance plan to address the filing requirement by April 5, 2024, which will also be reviewed during the April hearing.
納斯達克股票市場已通知Bruush Oral Care Inc. 不遵守最低出價和低價股票規則，這是繼續在納斯達克資本市場上市的先決條件。由於連續30個交易日的出價跌至1.00美元以下，連續十個交易日達到0.10美元或以下，該公司的證券面臨退市的風險。Bruush Oral Care已要求定於2024年4月25日舉行的納斯達克聽證會小組舉行聽證會，對除名決定提出上訴。聽證會的結果尚不確定。此外，該公司在提交截至2023年10月31日財年的20-F表年度報告時收到了有關拖欠行爲的通知。這種申報延遲是可能從清單中除名的另一個依據。Bruush Oral Care必須在2024年4月5日之前提交一份合規計劃以滿足申報要求，該計劃也將在4月的聽證會上進行審查。
納斯達克股票市場已通知Bruush Oral Care Inc. 不遵守最低出價和低價股票規則，這是繼續在納斯達克資本市場上市的先決條件。由於連續30個交易日的出價跌至1.00美元以下，連續十個交易日達到0.10美元或以下，該公司的證券面臨退市的風險。Bruush Oral Care已要求定於2024年4月25日舉行的納斯達克聽證會小組舉行聽證會，對除名決定提出上訴。聽證會的結果尚不確定。此外，該公司在提交截至2023年10月31日財年的20-F表年度報告時收到了有關拖欠行爲的通知。這種申報延遲是可能從清單中除名的另一個依據。Bruush Oral Care必須在2024年4月5日之前提交一份合規計劃以滿足申報要求，該計劃也將在4月的聽證會上進行審查。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。